Cite
MLA Citation
DW Dodick et al.. “A.07 Efficacy, safety, and tolerability of ubrogepant for the acute treatment of migraine: a single-attack phase 3 study, ACHIEVE I.” Canadian journal of neurological sciences, vol. 46, n.d., pp. S9–S10. http://access.bl.uk/ark:/81055/vdc_100084766142.0x00001e